1. Home
  2. TECH vs EPAM Comparison

TECH vs EPAM Comparison

Compare TECH & EPAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECH
  • EPAM
  • Stock Information
  • Founded
  • TECH 1976
  • EPAM 1993
  • Country
  • TECH United States
  • EPAM United States
  • Employees
  • TECH N/A
  • EPAM N/A
  • Industry
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • EPAM EDP Services
  • Sector
  • TECH Health Care
  • EPAM Technology
  • Exchange
  • TECH Nasdaq
  • EPAM Nasdaq
  • Market Cap
  • TECH 7.8B
  • EPAM 8.2B
  • IPO Year
  • TECH 1989
  • EPAM 2012
  • Fundamental
  • Price
  • TECH $49.15
  • EPAM $183.76
  • Analyst Decision
  • TECH Buy
  • EPAM Buy
  • Analyst Count
  • TECH 10
  • EPAM 16
  • Target Price
  • TECH $73.44
  • EPAM $229.00
  • AVG Volume (30 Days)
  • TECH 2.3M
  • EPAM 750.8K
  • Earning Date
  • TECH 05-07-2025
  • EPAM 05-08-2025
  • Dividend Yield
  • TECH 0.65%
  • EPAM N/A
  • EPS Growth
  • TECH N/A
  • EPAM N/A
  • EPS
  • TECH 0.83
  • EPAM 7.15
  • Revenue
  • TECH $1,208,770,000.00
  • EPAM $4,864,167,000.00
  • Revenue This Year
  • TECH $8.19
  • EPAM $14.70
  • Revenue Next Year
  • TECH $8.61
  • EPAM $7.82
  • P/E Ratio
  • TECH $59.07
  • EPAM $25.70
  • Revenue Growth
  • TECH 4.72
  • EPAM 4.72
  • 52 Week Low
  • TECH $46.44
  • EPAM $138.15
  • 52 Week High
  • TECH $85.57
  • EPAM $269.00
  • Technical
  • Relative Strength Index (RSI)
  • TECH 44.74
  • EPAM 65.02
  • Support Level
  • TECH $46.35
  • EPAM $156.21
  • Resistance Level
  • TECH $54.40
  • EPAM $189.62
  • Average True Range (ATR)
  • TECH 2.17
  • EPAM 4.67
  • MACD
  • TECH 0.27
  • EPAM 3.63
  • Stochastic Oscillator
  • TECH 34.78
  • EPAM 83.80

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About EPAM EPAM Systems Inc.

EPAM Systems is a global IT services firm that offers platform engineering, software development, and consulting services. EPAM's largest market is North America, which represents approximately 60% of revenue. Offerings span assisting companies with new technologies, such as artificial intelligence, virtual reality, and robotics.

Share on Social Networks: